[
  {
    "ts": null,
    "headline": "JPM26: Vertex hopes to match cystic fibrosis success in pain and kidney disease",
    "summary": "Vertex on track for “five launches in five disease areas over a five-year period” through emerging pain and renal franchises.",
    "url": "https://finnhub.io/api/news?id=15c46e3c813c95244c8ec4445bcc0b9603d47eddd3d4bfdb6b93961f3c807cb6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768317922,
      "headline": "JPM26: Vertex hopes to match cystic fibrosis success in pain and kidney disease",
      "id": 138086834,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex on track for “five launches in five disease areas over a five-year period” through emerging pain and renal franchises.",
      "url": "https://finnhub.io/api/news?id=15c46e3c813c95244c8ec4445bcc0b9603d47eddd3d4bfdb6b93961f3c807cb6"
    }
  },
  {
    "ts": null,
    "headline": "Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report",
    "summary": "Vertex Pharmaceuticals is scheduled to post its fourth-quarter results soon, and analysts project a double-digit earnings growth",
    "url": "https://finnhub.io/api/news?id=c5f36943c11daf9c0254442aaabcfee42fdab3fa0339353d569b8c2eb2b55575",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768314676,
      "headline": "Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report",
      "id": 138086835,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals is scheduled to post its fourth-quarter results soon, and analysts project a double-digit earnings growth",
      "url": "https://finnhub.io/api/news?id=c5f36943c11daf9c0254442aaabcfee42fdab3fa0339353d569b8c2eb2b55575"
    }
  }
]